Ferreira, Diana H.
Ryan, Richella
Smyth, Nina
Clow, Angela
Currow, David C.
Funding for this research was provided by:
National Health and Medical Research Council (APP1065571)
Article History
Received: 4 December 2024
Accepted: 9 April 2025
First Online: 23 April 2025
Declarations
:
: Ethics approval was obtained from relevant Health Human Research Ethics Committees before recruitment commenced. All participants gave informed written consent.
: The authors DF, RR, NS, AC report no competing interests. DC is an unpaid advisory board member for Helsinn Pharmaceuticals. He is a paid consultant and receives payment for intellectual property with Mayne Pharma and is a consultant with Specialised Therapeutics Australia Pty. Ltd.
: This study was approved by the Hunter New England Human Research Ethics Committee (Reference 15/12/16/3.06) in accordance with the Declaration of Helsinki.
: Not applicable.